Clinical trial
A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the…
NCT00162448 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00162448 |
|---|---|
| Title | A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators |
| Official title | Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Patients With Implanted Dual-Chamber Pacemakers or Defibrillators |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heart Diseases |
| Intervention type | Drug |
| Interventions | BMS-394136, Placebo |
| Enrollment | 36 |
| Start date | Jan 1, 2005 |
| First posted | Sep 13, 2005 |
| Last update posted | Aug 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: